SBIR/STTR Research Award
SBIR Topic 314- High Content Screening of 3D Cultured Cancer Cells
Award amount
$285,423Program and phase
SBIR · Phase IAward year
2013Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BioTime, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- JB7RMLG8U699
- Solicitation number
- Not reported
- Topic code
- NCI
Research abstract
Not Available
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Stroke
- Retinal tissue derived from human pluripotent stem cells for vision restoration
- Cell Targeting Peptides for Isolating Patient Specific Stem Cells
- Biodegradable, hyaluronic acid-based microcarriers for mesenchymal stem cell prop
- Resuscitating Blood-Substituted Hypothermic Dogs
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
6 SBIR/STTR records share this UEI (2004–2018). Reported award amounts total $3,762,961. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services